Development Level

Tbio 3 | 10,625
Tclin 1 | 602

Disease

Allergic hypersensitivity disease 3 | 123
Allergic rhinitis 3 | 92
Asthma 3 | 349
Cancer 3 | 2,346
psoriasis 3 | 6,685
Arthritis 2 | 248
Arthritis, Experimental 2 | 39
Atopic dermatitis 2 | 944
Autistic Disorder 2 | 320
Collagen disease 2 | 25
Common cold 2 | 63
Conjunctivitis 2 | 18
Dermatitis 2 | 141
Dermatitis, Atopic 2 | 45
Drug allergy 2 | 36
Eosinophilia 2 | 65
Hepatitis, Autoimmune 2 | 17
Hypersensitivity 2 | 63
Hypersensitivity reaction type II disease 2 | 235
Immediate hypersensitivity 2 | 8
Inflammatory bowel disease 2 | 142
Keratoconjunctivitis 2 | 11
Leishmaniasis 2 | 49
Lung disease 2 | 136
Mastocytosis 2 | 27
Pneumonia 2 | 133
Pulmonary Fibrosis 2 | 66
Renal Cell Carcinoma 2 | 199
Schistosomiasis 2 | 38
Sinusitis 2 | 30
Tetanus 2 | 66
lung cancer 2 | 4,473
malignant mesothelioma 2 | 3,163
ASTHMA, SUSCEPTIBILITY TO (finding) 1 | 6
Acquired immunodeficiency syndrome 1 | 164
Adult T-Cell Lymphoma/Leukemia 1 | 30
Allergic rhinitis (disorder) 1 | 12
Alopecia areata 1 | 37
Anemia 1 | 252
Aspergillosis 1 | 23
Asthma, susceptibility to 1 | 11
Autoimmune Diseases 1 | 33
Bronchial Hyperreactivity 1 | 13
Brucellosis 1 | 24
Candidiasis 1 | 48
Cardiomyopathies 1 | 90
Chagas disease 1 | 34
Colitis 1 | 46
Cryptococcosis 1 | 14
Dermatitis, Allergic Contact 1 | 66
Drug Eruptions 1 | 18
Drug-Induced Liver Injury 1 | 118
Encephalitis 1 | 54
Esophagitis 1 | 26
Fibrosis 1 | 40
Filariasis 1 | 21
Gastritis 1 | 44
HIV Infections 1 | 99
Hepatitis 1 | 61
Hepatitis B 1 | 103
Hepatitis C 1 | 90
Hodgkin Disease 1 | 16
Hodgkin's lymphoma 1 | 11
Human immunodeficiency virus type 1, susceptibility to 1 | 26
Hyperplasia 1 | 26
IgE RESPONSIVENESS, ATOPIC 1 | 8
Inflammation 1 | 109
Influenza 1 | 142
Ischemic stroke 1 | 12
Kawasaki disease 1 | 24
Kidney disease 1 | 397
Leishmaniasis, Cutaneous 1 | 8
Leprosy 1 | 77
Lichen planus 1 | 17
Lung diseases 1 | 48
Lupus Erythematosus, Systemic 1 | 73
Malaria 1 | 140
Malignant glioma 1 | 23
Metaplasia 1 | 3
Multiple Sclerosis 1 | 498
Myocarditis 1 | 17
Neuropathy 1 | 210
Non-alcoholic Fatty Liver Disease 1 | 40
Paracoccidioidomycosis 1 | 11
Pneumoconiosis 1 | 14
Premature Birth 1 | 9
Primary immunodeficiency disease 1 | 52
Psoriatic arthritis 1 | 85
Respiratory Hypersensitivity 1 | 18
Rhinitis 1 | 46
Toxoplasmosis 1 | 16
Trichinosis 1 | 7
Urticaria 1 | 53
Uveitis 1 | 103
Vascular disease 1 | 281
Waldenstrons macroglobulinemia 1 | 764
Weight decreased 1 | 18
interstitial lung disease 1 | 292
mucosa-associated lymphoid tissue lymphoma 1 | 480
tuberculosis 1 | 1,563

Tissue

Blood and immune system 4 | 17,994
Cardiovascular System 4 | 17,957
Digestive Tract 4 | 18,472
Endocrine System 4 | 18,511
Female tissues 4 | 18,646
Liver and Pancreas 4 | 18,135
Male tissues 4 | 17,968
Nervous System 4 | 18,560
Respiratory system 4 | 17,483
Skin and soft tissues 4 | 18,114
Urinary Tract 4 | 18,443

Target Family

Non-IDG 4 | 11,969

Grant Application

5R21NS054143-02 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin-4 receptor subunit alpha IL4R Tclin Non-IDG -2.23385 144.1 376
Interleukin-4 IL4 Tbio Non-IDG -3.96666 8890.7 1086
Interleukin-13 IL13 Tbio Non-IDG -3.28539 1774.2 682
Interleukin-13 receptor subunit alpha-2 IL13RA2 Tbio Non-IDG -1.19646 14.1 297